Next Article in Journal
Chlorotoxin—A Multimodal Imaging Platform for Targeting Glioma Tumors
Previous Article in Journal
Analysis of the Fungal Community in Ziziphi Spinosae Semen through High-Throughput Sequencing
Previous Article in Special Issue
A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes
Article Menu

Export Article

Open AccessEditorial
Toxins 2018, 10(12), 495;

Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine

Department of Anesthesia and Perioperative Care, University of California, San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, Room 3C-38, 1001 Potrero Avenue, San Francisco, CA 94110, USA
Authors to whom correspondence should be addressed.
Received: 20 November 2018 / Accepted: 22 November 2018 / Published: 26 November 2018
(This article belongs to the Special Issue Botulinum Neurotoxins Antibody and Vaccine)
Full-Text   |   PDF [186 KB, uploaded 26 November 2018]
Note: In lieu of an abstract, this is an excerpt from the first page.


Botulism, caused by exposure to one or more of the eight serotypes of botulinum neurotoxins (BoNTs) (BoNT/A through H), is often fatal without rapid treatment. [...] View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Lou, J.; Marks, J.D. Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine. Toxins 2018, 10, 495.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top